Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2020. Start Trial.
Date Value
November 13, 2026 2.376
November 12, 2026 2.546
November 11, 2026 2.665
November 10, 2026 2.703
November 09, 2026 2.422
November 06, 2026 2.426
November 05, 2026 2.175
November 04, 2026 2.201
November 03, 2026 2.356
November 02, 2026 2.378
October 30, 2026 2.425
October 29, 2026 2.357
October 28, 2026 2.433
October 27, 2026 2.332
October 26, 2026 2.312
October 23, 2026 2.426
October 22, 2026 2.496
October 21, 2026 2.384
October 20, 2026 2.348
October 19, 2026 2.362
October 16, 2026 2.300
October 15, 2026 2.285
October 14, 2026 2.129
October 13, 2026 2.24
October 12, 2026 2.28
Date Value
October 09, 2026 2.384
October 08, 2026 2.397
October 07, 2026 2.376
October 06, 2026 2.251
October 05, 2026 2.380
October 02, 2026 2.256
October 01, 2026 2.318
September 30, 2026 2.289
September 29, 2026 2.219
September 28, 2026 2.278
September 25, 2026 2.306
September 24, 2026 2.334
September 23, 2026 2.442
September 22, 2026 2.279
September 21, 2026 2.400
September 18, 2026 2.391
September 17, 2026 2.391
September 16, 2026 2.278
September 15, 2026 2.250
September 14, 2026 2.208
September 11, 2026 2.278
September 10, 2026 2.251
September 09, 2026 2.250
September 08, 2026 2.334
September 04, 2026 2.310

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 17.59
Anika Therapeutics, Inc. 1.265
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.476

Price to Book Value Related Metrics

PS Ratio 3.675
Price 0.8392
Earnings Yield -75.26%
Market Cap 37.26M